Accéder au contenu
Merck
  • Effects of human amniotic fluid and membrane in the treatment of Achilles tendon ruptures in locally corticosteroid-induced Achilles tendinosis: an experimental study on rats.

Effects of human amniotic fluid and membrane in the treatment of Achilles tendon ruptures in locally corticosteroid-induced Achilles tendinosis: an experimental study on rats.

Foot and ankle surgery : official journal of the European Society of Foot and Ankle Surgeons (2009-02-17)
Ibrahim Coban, Ismail Safa Satoğlu, Alper Gültekin, Burçin Tuna, Hasan Tatari, Mustafa Fidan
RÉSUMÉ

To determine the effects of human amniotic fluid and membrane in the treatment of Achilles tendon ruptures, 72 tendons of 36 Wistar rats were injected with betamethasone sodium phosphate. By the end of fourth week, both tendons were tenotomized and repaired, then the samples were divided into three groups. The first group was left untreated after suturing. Human amniotic fluid was injected to the second and amniotic fluid and membrane were both administered to the third group. Twenty-four tendons were scored at the end of the first week, and 24 at the end of the second week histopathologically, and 24 biomechanically at the end of the third week. There was a significant statistical difference only between the histopathological results of Groups 2 and 3 at the first week. Human amniotic membrane and fluid do not add anything to the healing process of Achilles tendon ruptures in the early phase.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Betamethasone 21-phosphate disodium, ≥97%
Betamethasone sodium phosphate, European Pharmacopoeia (EP) Reference Standard